Notice of NIDA's Participation in PA-14-307 "Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44)"

Notice Number: NOT-DA-14-025

Key Dates
Release Date: August 8, 2014

Related Announcements
PA-14-307

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this Notice is to inform potential applicants of the National Institute on Drug Abuse (NIDA)'s participation, effective immediately, in the Funding Opportunity Announcement (FOA), PA-14-307, entitled "Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44)".

PA-14-307 has been updated in the following ways to reflect NIDA's participation in this FOA.

Part 1. Overview Information

Components of Participating Organizations
National Center for Advancing Translational Sciences (NCATS)
National Institute on Drug Abuse (NIDA)

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.350, 93.279

Part 2. Section VII. Agency Contacts

Scientific/Research Contact(s)
Kristopher Bough, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-9800
Email: boughk@nida.nih.gov

Financial/Grants Management Contact(s)
Cheryl Nathaniel
National Institute on Drug Abuse (NIDA)
Telephone: 202-526-0108
Email: nathanic@nida.nih.gov

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Kristopher Bough, Ph.D.
National Institute on Drug Abuse (NIDA)
Phone: 301-443-9800
Email: boughk@nida.nih.gov

 

NIH Office of Extramural Research Logo
Department of Health and Human Services (HHS) - Home Page
Department of Health
and Human Services (HHS)
USA.gov - Government Made Easy
NIH... Turning Discovery Into Health®


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.